Business article - November 4, 2024
Navigating the Financial Landscape: Downsizing
Downsizing a company is one of the most difficult decisions a chief executive can make, after which comes the equally painful decision of when to do it.
Profiles in Science - June 24, 2024
Exclusive interview: Jens Juul Holst
His is not a household name, but the drugs developed thanks to Danish scientist Jens Juul Holst’s research certainly are.
Profiles in Biotech - April 23, 2024
Mia Phillipson: Pioneering immunotherapies
Despite being the co-founder of Ilya Pharma and co-director at the Science for Life Laboratory (SciLifeLab), Dr. Mia Phillipson, considers herself a scientist foremost, not an entrepreneur.
Investor interview - April 17, 2024
Exclusive interview: Thomas Eldered predicts 2024
Personalized medicine, weight loss remedies and new treatments for widespread ailments are among the rising areas of high interest in the biotechnology and therapeutic arenas, according to executive chairman of Flerie Invest, Thomas Eldered. Thomas Eldered talked with Nordic Life Science about the Nordic and global life science financial landscapes and Flerie’s role in funding […]
Nobel Prize Laureate - December 20, 2023
Katalin Karikó: “Decades and decades of work were involved”
Scientific research demands years, sometimes a lifetime’s worth, of persistence. One of the 2023 Nobel Prize winners in Physiology or Medicine, Dr. Katalin Karikó, PhD, has shown more determination than most. Despite a series of setbacks, she forged ahead on messenger RNA research that contributed to a vaccine for the COVID-19 virus.
Nobel Prize Laureate - December 20, 2023
Drew Weissman: Unlocking the power of mRNA
Drew Weissman was one of the 2023 Nobel Prize in Physiology or Medicine for his work on messenger RNA that paved the way for the COVID-19 vaccine.